Specimen Banking From Patients With Lung Cancer
Launched by UNIVERSITY OF COLORADO, DENVER · Apr 25, 2012
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a collection of samples, called a specimen bank, from patients with lung cancer. The goal is to use these samples for future research that could help doctors find lung cancer earlier and develop better treatments. By understanding lung cancer more deeply, researchers hope to improve screening methods and prevention strategies for patients.
If you or a loved one is undergoing tests for lung cancer and are between the ages of 65 and 104, you might be eligible to participate in this study. To join, you would need to provide both verbal and written consent. Participants can expect to provide samples and help advance research that could lead to better outcomes for future lung cancer patients. It's important to note that if someone does not agree to participate, they cannot be included in the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
- • 2. Oral and written informed consent
- Exclusion Criteria:
- • 1. Any individual who does not give oral and written consent for participation
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Adriaan VanBokhoven, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials